glucose, (beta-d)-isomer has been researched along with sym-trinitrobenzene in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, EY; Choi, SC; Chung, HT; Jun, CD; Kim, KS; Kim, S; Kim, SW; Kim, TH; Kim, YS; Kimm, KC; Lee, HJ; Lee, MH; Oh, BS; Oh, HC; Oh, HM; Oh, JM; Pae, HO; Park, DS; Seo, GS; Woo, WH | 1 |
Majewska-Szczepanik, M; Marcińska, K; Strzepa, A; Szczepanik, M; Wen, L | 1 |
2 other study(ies) available for glucose, (beta-d)-isomer and sym-trinitrobenzene
Article | Year |
---|---|
Catalposide, a compound isolated from catalpa ovata, attenuates induction of intestinal epithelial proinflammatory gene expression and reduces the severity of trinitrobenzene sulfonic Acid-induced colitis in mice.
Topics: Animals; Colitis; Cytokines; Disease Models, Animal; Down-Regulation; Gene Expression Regulation; Glucosides; Inflammation; Intestinal Mucosa; Male; Mice; Mice, Inbred BALB C; Severity of Illness Index; Signal Transduction; Trinitrobenzenes | 2004 |
Epicutaneous immunization with TNP-Ig and Zymosan induces TCRαβ+ CD4+ contrasuppressor cells that reverse skin-induced suppression via IL-17A.
Topics: Administration, Cutaneous; Animals; Antigens; CD4-Positive T-Lymphocytes; Dermatitis, Contact; Haptens; Immunity, Innate; Immunization; Immunoglobulins; Immunosuppression Therapy; Interleukin-17; Lymph Nodes; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Myeloid Differentiation Factor 88; Receptors, Antigen, T-Cell, alpha-beta; Skin; Toll-Like Receptor 2; Transforming Growth Factor beta; Trinitrobenzenes; Vaccination; Zymosan | 2014 |